Design and synthesis of hybrid solids based on the tetravanadate core toward improved catalytic properties

Recent advances in oxidative catalytic applications of polyoxovanadate-based inorganic-organic hybrids

Polyoxovanadates (POVs) have received widespread attention in catalytic applications due to their various structures and remarkable redox properties. By introducing a second transition metal, POV-based inorganic-organic hybrid (POVH) catalysts show increasing stability and more catalytic active sites compared with pure POVs. In this perspective article, POVH materials as oxidative catalysts have been classified into two main categories according to the interactions between transition metal-complex units and POV clusters: (i) hybrids with metal-organic units act as isolated cations and (ii) hybrids with an organic ligand coordinate to the second transition metal, which is further linked to a POV cluster via oxygen bridges directly or indirectly to give zero-, one-, two- or three-dimensional supramolecular structures. The oxidative conversion of organic compounds, including thiophene derivatives, thioethers, alkanes, alcohols, and alkenes, and oxidative detoxification of a sulfur mustard simulant or degradation of lignin, along with the oxidative photo/electrocatalytic transformation of organic compounds catalyzed by POVH materials, are discussed in detail. Furthermore, the challenges and prospects toward the development of POVH catalysts are explored briefly from our perspectives.

Cyclo-tetravanadate bridged copper complexes as potential double bullet pro-metallodrugs for cancer treatment

Over the last decade, copper and vanadium complexes have shown promising properties for the treatment of several types of cancer. In particular, Casiopeinas®, a group of copper-based complexes, has received specific attention, and their mechanism of action has been extensively studied since their structure is simple and their synthesis may be affordable. Similarly, vanadium-containing compounds in the form of complexes and simple polyoxovanadates have also been studied as antitumor agents. Here, potential prodrugs that would release the two metals, V and Cu, in usable form to act in conjunction against cancer cells are reported. The new series of Casiopeinas-like compounds are bridged by a cyclotetravanadate ion with the generic formula [Cu(N,N')(AA)]₂•(V₄O₁₂), where (N,N') represent 1,10-phenanthroline and 2,2'-bipyridine, and (AA) are aminoacidate ions (Lysine and Ornithine). The compounds were characterized by elemental analysis, single-crystal X-ray diffraction and Visible, FTIR, and Raman spectroscopies, as well as ⁵¹V NMR, EPR, and Thermogravimetric Analysis. Additionally, theoretical calculations based on the Density Functional Theory (DFT) were carried out to model the compounds. Optimized structures, theoretical IR, and Raman spectra were also obtained, as well as docking analysis to test DNA interactions with the casiopeina-like complexes. The compounds may act as prodrugs by providing acting molecules that have showed potential pharmacological properties for the treatment of several types of cancer.

Inorganic–organic hybrid polyoxovanadates based on [V4O12]4− or [VO3]22− clusters: controllable synthesis, crystal structures and catalytic properties in selective oxidation of sulfides

Three inorganic–organic hybrid polyoxovanadates have been synthesized. Among them, complex [Ni₂(1-vIM)₇H₂O][V₄O₁₂]·H₂O (1) exhibits extraordinary heterogeneous catalytic performance in the selective oxidation of sulfides using H₂O₂ as the oxidant.